our products
our products
information_top

Call us at:

(818)591-3030

USA

Click here to send us an email
tel_section

Diagnostic Automation Question & AnswerDiagnostic Automation Question & Answer Diagnostic Automation Articles Diagnostic Automation kit images Diagnostic Automation videos


Pregnancy Rapid tests

CA-19-9 ELISA kit

Name

CA-19-9 ELISA kit

Full name

Human CA-19-9 ELISA Test Kit

Category Name Cancer ELISA kits
Test 96
Method ELISA method: Enzyme Linked Immunosorbent Assay
Principle Sandwich Complex
Detection Range 0-240U/mL
Sample 50ul serum
Specificity 97%
Sensitivity 5U/mL
Total Time ~140 min
Shelf Life 12-14 Months from the manufacturing date

Item #:                    6909-16   Quantity:               

CA-19-9 ELISA kit


CA-19-9 ELISA kit

callback phone number email us


CA-19-9 ELISA kit description:




The CA19-9 EIA test kit is an ELISA assay for the quantitative measurement of CA19-9 in human serum. CA19-9 elisa kit is intended for use as a monitoring and screening test for breast cancer.




Material Provided with CA199 ELISA Kit:
1. Microtiter wells coated with Murine monoclonal anti-CA199
2. Assay buffer
3. Enzyme conjugate reagent
4. CA19-9 reference standards
5. TMB Substrate
6. Stop solution
7. Wash Buffer Concentrate 50X

Materials Required, not Provided:
1. Precision pipettes
2. Distilled or deionized water
3. EIA kit Microplate Washer
4. EIA kit Microplate Reader with a 450 nm




CA190 ELISA Kit Background Information:
CA19-9 represents the most important and basic carbohydrate tumor marker. Recent reports indicate that the serum CA19-9 level is frequently elevated in the serum of subjects with various gastrointestinal malignancies, such as pancreatic, colorectal, gastric and hepatic carcinomas.
Together with CEA, elevated CA19-9 is suggestive of gallbladder neoplasm in the setting of inflammatory gallbladder disease. A persistently rising serum CA19-9 value may be associated with progressive malignant disease and poor therapeutic response. A declining CA19-9 value may be indicative of a favorable prognosis and good response to treatment.




CA199 ELISA Test Principle:
The CA19-9 EIA test is a solid phase two-site immunoassay. The molecules of CA199 are sandwiched between two monoclonal antibodies. One coated to the bottom of the wells of the microtiter plates and the other linked to the horseradish peroxidase enzyme conjugate. After incubation and washing, the enzymatic reaction develops a color which is proportional to the amount of CA199 molecules present in the assay. For additional details please refer to the instructions for use.




Notable features of Cancer ELISA Kits:
User-friendly directions and explanation of test procedures
Simple and safe reagent preparation
Clear instructions on specimen collection
Comprehensive package of required materials
Explicit quality control and storage guidelines
Reliable and easy-to-read test results

Product inserts for all Cancer ELISA kits follow a similar method. See the CA199 ELISA Kit product insert for specific details on preparation, procedures, quality control, and test result interpretation.


Diagnostic Automation Inc. also provides other Autoimmune Disease ELISA Kits. For more information about ELISA Kits, Rapid Tests, IFA Kits, CLIA Test Kits, or Serology tests, please see our website home page, or contact our Customer Service Representatives at 818-591-3030 .






Product Note:

This serum CA199 elisa test kit provides useful tumor marker information for patients in clinical remission, following treatment.